Search Results - thomas+vondriska

2 Results Sort By:
A Novel Biomarker and Therapeutic Target for Atrial Fibrillation in Humans (UCLA Case No. 2024-041)
UCLA researchers at the Geffen School of Medicine have identified a novel biomarker and therapeutic target for early diagnosis and treatment of post-operative atrial fibrillation. BACKGROUND: Post-operative atrial fibrillation (POAF) is a common complication following cardiac surgery, affecting 30-50% of patients. Patients who develop POAF have an...
Published: 3/26/2026   |   Updated: 3/26/2026   |   Inventor(s): Thomas Vondriska, Matthew Fischer
Keywords(s):  
Category(s): Diagnostic Markers > Targets And Assays, Platforms > Diagnostic Platform Technologies, Therapeutics > Cardiovascular
Histone H1 as a Therapeutic Target for Fibrosis (UCLA Case No. 2023-148)
UCLA researchers from the David Geffen School of Medicine have identified linker histone H1 as a critical regulator of pathologic gene expression and cellular mechanics, establishing its potential role as a therapeutic target for the treatment of fibrosis. BACKGROUND: Heart failure affects ~6 million Americans and has a 5-year survival rate of ~50%...
Published: 10/29/2025   |   Updated: 10/29/2025   |   Inventor(s): Thomas Vondriska
Keywords(s):  
Category(s): Therapeutics > Cardiovascular